CV3 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA
Abstract
Authors
XB Chen CY Wang S Eggington M Zhu
XB Chen CY Wang S Eggington M Zhu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now